{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:11:27Z","timestamp":1793153487335,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006727","name":"University of Kansas Medical Center","doi-asserted-by":"publisher","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}],"id":[{"id":"10.13039\/100006727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","award":["KL2TR002367"],"award-info":[{"award-number":["KL2TR002367"]}],"id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002367"],"award-info":[{"award-number":["KL2TR002367"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118755","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:59:40Z","timestamp":1762855180000},"page":"118755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Plasma metabolic profiling identifies elevated hippurate as a potential biomarker of methotrexate non-response in juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8513-673X","authenticated-orcid":false,"given":"Amar","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1088-2015","authenticated-orcid":false,"given":"Mara L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118755_bib1","unstructured":"R. Pahwa, A. Goyal, and I. Jialal, \u201cChronic Inflammation,\u201d in StatPearls, Treasure Island (FL): StatPearls Publishing, 2024. Accessed: Dec. 20, 2023. [Online]. Available: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493173\/\u3009."},{"key":"10.1016\/j.biopha.2025.118755_bib2","unstructured":"\u201cAbout Arthritis and R.A.\u201d Accessed: Dec. 20, 2023. [Online]. Available: \u3008https:\/\/globalranetwork.org\/project\/disease-info\/\u3009."},{"key":"10.1016\/j.biopha.2025.118755_bib3","unstructured":"N. Washington, Juvenile Arthritis. Accessed: Dec. 20, 2023. [Online]. Available: \u3008https:\/\/rheumatology.org\/patients\/juvenile-arthritis\u3009."},{"key":"10.1016\/j.biopha.2025.118755_bib4","unstructured":"A. Thatayatikom, R. Modica, and A. De Leucio, Juvenile Idiopathic Arthritis,\u201d in StatPearls, Treasure Island (FL): StatPearls Publishing, 2024. Accessed: Apr. 20, 2024. [Online]. Available: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554605\/\u3009."},{"key":"10.1016\/j.biopha.2025.118755_bib5","unstructured":"Juvenile Idiopathic Arthritis. Accessed: Dec. 20, 2023. [Online]. Available: \u3008https:\/\/my.clevelandclinic.org\/health\/diseases\/10370-juvenile-idiopathic-arthritis\u3009."},{"issue":"S3","key":"10.1016\/j.biopha.2025.118755_bib6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118755_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105491","article-title":"Glucocorticoids in rheumatoid arthritis: balancing benefits and harm by leveraging the therapeutic window of opportunity","volume":"90","author":"Doumen","year":"2023","journal-title":"Jt. Bone Spine"},{"issue":"6","key":"10.1016\/j.biopha.2025.118755_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","article-title":"Use of biologics in rheumatoid arthritis: current and emerging paradigms of care","volume":"33","author":"Curtis","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2025.118755_bib9","unstructured":"R. Abree, \u201cFirst Medications for JIA.\u201d Accessed: Dec. 20, 2023. [Online]. Available: \u3008https:\/\/www.arthritis.org\/drug-guide\/medication-topics\/first-medications-for-jia\u3009."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","article-title":"Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting","volume":"16","author":"On behalf of the Rheumatology Italian Study Group","year":"2018","journal-title":"Pedia Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2025.118755_bib11","article-title":"Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis","volume":"84","author":"Calvo","year":"2016","journal-title":"An. De. Pedia\u00eda"},{"issue":"7","key":"10.1016\/j.biopha.2025.118755_bib12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12969-020-0407-5","article-title":"Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance","volume":"18","author":"Smits","year":"2020","journal-title":"Pedia Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2025.118755_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/rheumatology\/kez048","article-title":"Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis","volume":"58","author":"Kearsley-Fleet","year":"2019","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.biopha.2025.118755_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118755_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105887","article-title":"A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis","volume":"173","author":"Daraghmeh","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbspin.2019.04.002","article-title":"Is prediction of clinical response to methotrexate in individual rheumatoid arthritis patients possible? A systematic literature review","volume":"87","author":"Roodenrijs","year":"2020","journal-title":"Jt. Bone Spine"},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/ijr.12.81","article-title":"Role of methotrexate in juvenile idiopathic arthritis: where we have been and where we are going","volume":"8","author":"Becker","year":"2013","journal-title":"Int. J. Clin. Rheumatol."},{"key":"10.1016\/j.biopha.2025.118755_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152056","article-title":"Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis","volume":"56","author":"Medcalf","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118755_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.768599","article-title":"Metabolomic profiling identifies exogenous and microbiota-derived metabolites as markers of methotrexate efficacy in Juvenile idiopathic arthritis","volume":"12","author":"Funk","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118755_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.678753","article-title":"Serum metabolite biomarkers predictive of response to PD-1 blockade therapy in non-small cell lung cancer","volume":"8","author":"Nie","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2025.118755_bib22","article-title":"Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-023-00317-z","article-title":"Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling","volume":"11","author":"Hishinuma","year":"2023","journal-title":"Cancer Metab."},{"key":"10.1016\/j.biopha.2025.118755_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2016.00030","article-title":"Feature selection methods for early predictive biomarker discovery using untargeted metabolomic data","volume":"3","author":"Grissa","year":"2016","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib25","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41598-017-02442-4","article-title":"Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects","volume":"7","author":"Hinton","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118755_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2020.11.008","article-title":"Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics","volume":"37","author":"Saigusa","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib27","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1038\/s41598-017-13722-4","article-title":"Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome","volume":"7","author":"Pallister","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41598-020-80093-8","article-title":"An enriched biosignature of gut microbiota-dependent metabolites characterizes maternal plasma in a mouse model of fetal alcohol spectrum disorder","volume":"11","author":"Virdee","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","article-title":"Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease","volume":"31","author":"Zhu","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","article-title":"Gut microbiota-generated phenylacetylglutamine and heart failure","volume":"16","author":"Romano","year":"2023","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.biopha.2025.118755_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.675158","article-title":"Gut-derived metabolite phenylacetylglutamine and white matter hyperintensities in patients with acute ischemic stroke","volume":"13","author":"Yu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118755_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41569-020-0367-y","article-title":"Novel gut microbiota-derived metabolite promotes platelet thrombosis via adrenergic receptor signalling","volume":"17","author":"Huynh","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118755_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","article-title":"Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism","volume":"8","author":"Gao","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118755_bib34","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/microorganisms11071825","article-title":"Microbial-derived tryptophan metabolites and their role in neurological disease: anthranilic acid and anthranilic acid derivatives","volume":"11","author":"Shaw","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib35","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1038\/s41467-021-26209-8","article-title":"High-coverage metabolomics uncovers microbiota-driven biochemical landscape of interorgan transport and gut-brain communication in mice","volume":"12","author":"Lai","year":"2021","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.biopha.2025.118755_bib36","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1007\/s00018-018-2901-1","article-title":"Implication of gut microbiota metabolites in cardiovascular and metabolic diseases","volume":"75","author":"Brial","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118755_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tim.2011.05.006","article-title":"Understanding the role of gut microbiome\u2013host metabolic signal disruption in health and disease","volume":"19","author":"Holmes","year":"2011","journal-title":"Trends Microbiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118755_bib38","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/gutjnl-2020-323314","article-title":"Human and preclinical studies of the host\u2013gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health","volume":"70","author":"Brial","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118755_bib39","doi-asserted-by":"crossref","first-page":"1200391","DOI":"10.3389\/fendo.2023.1200391","article-title":"Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice","volume":"14","author":"Toft","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118755_bib40","series-title":"Nutrigenomics and Proteomics in Health and Disease: Towards A Systems-level Understanding of Gene-diet Interactions","year":"2017"},{"key":"10.1016\/j.biopha.2025.118755_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1200391","article-title":"Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice","volume":"14","author":"Toft","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118755_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","article-title":"Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response","volume":"16","author":"Scher","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2025.118755_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1131933","article-title":"Relationship between gut microbiota and rheumatoid arthritis: a bibliometric analysis","volume":"14","author":"Dong","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118755_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41584-021-00582-6","article-title":"\"Gut microbiome could predict drug response in RA","volume":"17","author":"Onuora","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118755_bib45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.41622","article-title":"The pretreatment gut microbiome is associated with lack of response to methotrexate in new-onset rheumatoid arthritis","volume":"73","author":"Artacho","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.biopha.2025.118755_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1189036","article-title":"Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis","volume":"14","author":"Fan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118755_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","article-title":"Tryptophan and indole metabolism in immune regulation","volume":"70","author":"Fiore","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13229-018-0218-4","article-title":"Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli","volume":"9","author":"Bent","year":"2018","journal-title":"Mol. Autism"},{"issue":"11","key":"10.1016\/j.biopha.2025.118755_bib49","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.3390\/ijms22115763","article-title":"Integration of the microbiome, metabolome and transcriptomics data identified novel metabolic pathway regulation in colorectal cancer","volume":"22","author":"Bisht","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2025.118755_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903526","article-title":"Dual role of indoles derived from intestinal microbiota on human health","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118755_bib51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/microorganisms10040740","article-title":"Genomics-based reconstruction and predictive profiling of amino acid biosynthesis in the human gut microbiome","volume":"10","author":"Ashniev","year":"2022","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.biopha.2025.118755_bib52","doi-asserted-by":"crossref","DOI":"10.46718\/JBGSR.2021.09.000225","article-title":"Tryptophan is linking metabolism to inflammation in juvenile idiopathic arthritis","volume":"9","author":"Brunner","year":"2021","journal-title":"JBGSR"},{"issue":"1","key":"10.1016\/j.biopha.2025.118755_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ph12010009","article-title":"Juvenile arthritis patients suffering from chronic inflammation have increased activity of both IDO and GTP-CH1 pathways but decreased BH4 efficacy: implications for well-being, including fatigue, cognitive impairment, anxiety, and depression","volume":"12","author":"Korte-Bouws","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118755_bib54","article-title":"A systematic review and meta-analysis of the kynurenine pathway of tryptophan metabolism in rheumatic diseases","volume":"14","author":"Mangoni","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118755_bib55","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis","volume":"30","author":"Schroecksnadel","year":"2003","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118755_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/08916934.2014.914507","article-title":"1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis","volume":"47","author":"Pigott","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biopha.2025.118755_bib57","doi-asserted-by":"crossref","DOI":"10.4137\/CPath.S39930","article-title":"IDO2: a pathogenic mediator of inflammatory autoimmunity","author":"Merlo","year":"2016","journal-title":"Clin. Med. Insight. Pathol. 9"},{"key":"10.1016\/j.biopha.2025.118755_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1200391","article-title":"Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice","volume":"14","author":"Toft","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118755_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2022.959189","article-title":"Indole and p-cresol in feces of healthy subjects: concentration, kinetics, and correlation with microbiome","volume":"2","author":"Candeliere","year":"2022","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118755_bib60","first-page":"425","article-title":"Update on biologic therapy in Juvenile idiopathic arthritis: a five-year narrative review","volume":"19","author":"Civino","year":"2025","journal-title":"Biologics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:57:37Z","timestamp":1777013857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S0753332225009497"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118755","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma metabolic profiling identifies elevated hippurate as a potential biomarker of methotrexate non-response in juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118755"}}